Pfizer CEO Read Will Pass The Torch To Bourla In 2019
Executive Summary
Chief Operating Officer Albert Bourla will succeed Ian Read as CEO of Pfizer, taking over the top spot at a steady point in the big pharma's evolution. Bourla's near-term challenges will be navigating the loss of Lyrica and the changing US health care dynamics.
You may also be interested in...
Pfizer's Bourla: "I Think We Forgot What It Looks Like To Grow"
The big pharma CEO reflected on his first year of leadership at Pfizer during the Forbes Healthcare Summit and talked about executing on a plan to deliver 6% growth through 2026.
On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019
Presiding over his last earnings call as the CEO of Pfizer, Ian Read was pressed about the company's drug pricing strategy for 2019 amid push back from the Trump Administration.
On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019
Presiding over his last earnings call as the CEO of Pfizer, Ian Read was pressed about the company's drug pricing strategy for 2019 amid push back from the Trump Administration.